Skip to content

Effect of Intravenous Nutrition and Epidural Analgesia on Protein Loss After Surgery

Hypocaloric Isonitrogenous Nutrition and Epidural Analgesia: a Novel Strategy to Induce Anabolism After Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00614133
Enrollment
22
Registered
2008-02-13
Start date
2004-06-30
Completion date
2007-06-30
Last updated
2008-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Protein Catabolism

Keywords

protein metabolism, surgery, parenteral nutrition

Brief summary

Loss of muscle mass and body protein are the main causes of fatigue after bowel surgery, which may result in a longer hospital stay and a higher rate of complications. This particularly applies to malnourished patients with cancer who undergo surgery with less muscle protein reserves than patients who are well-nourished. Anesthesiologists can favourably influence these undesirable consequences of surgery by choosing the type of pain treatment, i.e. analgesia. Our group recently observed that pain treatment with epidural catheters (these are placed in the so called epidural space, which lies between the spine and the skin of the back), in contrast to the more conventional use of intravenous morphine, can prevent the loss of body protein after surgery. The goal of the present research program is to study whether this protein sparing effect of epidural analgesia can be further augmented if we feed our patients intravenously with glucose and protein starting the day prior to surgery. We believe that this new concept will not only avoid the increased protein loss after surgery, but will also help patients to build up new protein which is needed to fight the stress caused by the operation.

Detailed description

The major objective of the nutritional management of surgical patients is to accelerate wound healing and increase resistance to infection while preventing wastage of functional and structural proteins. Parenteral nutrition represents a useful strategy to achieve this goal, particularly in patients undergoing major abdominal procedures with temporary intolerance to oral feeding. At present administration of large, hypercaloric amounts of glucose together with amino acids is the only nutritional modality to establish a positive protein balance (anabolism) after surgery. The fact that hyperalimentation requires central venous cannulation, causes hyperglycemia and is associated with increased morbidity is an impediment to its routine use. Attempts to induce anabolism by diminishing the glucose load to iso- or hypocaloric quantities failed because of * failure to control for type and quality of perioperative analgesia * inadequate assessment of the patient's catabolic status prior to surgery with subsequent * lack of individualization of energy and substrate supply. We recently demonstrated that segmental pain relief by epidural analgesia facilitates oxidative glucose utilization thereby decreasing the amount of glucose necessary to attenuate protein losses after surgery. Hypocaloric glucose and epidural analgesia prevented the postoperative increase in protein oxidation, but only if preoperative fasting was avoided, i.e. the glucose infusion was started 24 hours before surgery. We also showed that patients with epidural analgesia could be rendered anabolic by short term administration of glucose and amino acids. Based on our findings of anti-catabolic and anabolic effects of epidural analgesia in the presence of energy and substrate supply we now propose that epidural analgesia and hypocaloric parenteral nutrition initiated 24 hours before colorectal surgery will produce a more positive postoperative protein balance including a greater muscle protein synthesis than when initiated with skin incision. In order to test the validity of this assumption, patients scheduled for elective colorectal cancer surgery will be randomly assigned to an early or late feeding protocol. Early nutrition will start 24 hours prior to surgery, late nutrition will commence with surgical skin incision. Nutrition will be adjusted to provide 50% of the patient's actual energy expenditure as glucose and 20% as amino acids. The stable isotope tracer L-\[1-13C\]leucine will be applied to assess whole body protein breakdown, amino acid oxidation and protein synthesis. A positive protein balance (difference between protein synthesis and protein breakdown) will be used as an indicator of anabolism. Because whole body protein kinetics provide no insight into metabolic processes at organ level (muscle, liver), the fractional synthesis rates of albumin, fibrinogen and muscle protein will also be determined after surgery. The demonstration of anabolic effects of epidural analgesia and nutrition with less than half the commonly used energy would have a valuable practical application. If the nutrient load can be decreased, use can be made of peripheral veins and hyperglycemia can be avoided, thus making nutritional therapy more efficacious, safer and available to more patients.

Interventions

Glucose and amino acids intravenously starting 20 hours before the operation until the second postoperative day. Glucose provides 50% and amino acids 20% of each patient's measured resting energy expenditure.

OTHERIntravenous nutrition with glucose and amino acids.

Glucose and amino acids intravenously starting with surgical skin incision until the second postoperative day. Glucose provides 50% and amino acids 20% of each patient's measured resting energy expenditure.

Sponsors

McGill University Health Centre/Research Institute of the McGill University Health Centre
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* American Society of Anesthesiologists \<3 * colorectal surgery for non-metastatic colorectal carcinoma including right and left hemicolectomy, transverse, subtotal and total colectomy, sigmoid resection * ability to give informed consent

Exclusion criteria

* signs of severe malnutrition or obesity: body mass index \<18 or \>25 \>10% involuntary body weight loss over the preceding 6 months serum albumin \<21 g/L * significant cardiorespiratory, hepatic, renal and neurological disease * ingestion of drugs known to affect protein, glucose and lipid metabolism (for example steroids) * musculoskeletal or neuromuscular disease * severe anemia (hemoglobin \<10 g/dL) * pregnancy * history of severe sciatica or back surgery or other conditions which contraindicate the use of epidural catheters

Design outcomes

Primary

MeasureTime frame
protein balancetwo days after surgery

Secondary

MeasureTime frame
albumin synthesis, fibrinogen synthesis, total plasma protein synthesis, mRNA expression of ubiquitintwo days after surgery

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 4, 2026